Occam Crest Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.49M Buy
+35,500
New +$153K 1.29% 22
2026
Q1
Sell
-300
Closed -$161K 35
2025
Q4
$161K Sell
300
-6,700
-96% -$25.9K 0.11% 30
2025
Q3
$2.3M Buy
+7,000
New +$19.8K 1.4% 24

Other funds holding PGEN

Occam Crest Management's PGEN Position: Q2 2026 in Review

Occam Crest Management reduced its Precigen (PGEN) stake by 16% in Q2 2026, selling an estimated $2.87M and leaving 3,605,941 shares worth $19.7M. The position accounts for 10.2% of the portfolio, ranked #2.

Occam Crest Management first reported a position in PGEN in Q3 2025 and has held it in 4 quarters since. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Occam Crest Management held 3,605,941 shares of Precigen worth $19.7M as of Q2 2026.
  • Occam Crest Management sold 663,110 Precigen shares in Q2 2026, an estimated $2.87M.
  • Precigen made up 10.2% of Occam Crest Management's portfolio in Q2 2026, its #2 holding.
  • Occam Crest Management first reported a position in Precigen in Q3 2025 and has held it in 4 quarters since.
  • 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Occam Crest Management's 13F filing for Q2 2026, filed 14 Aug 2026.